Azelis buys UK pharmaceuticals supplier

European speciality chemicals distributor, Azelis, is to acquire UK-based S&D Group for an undisclosed amount.

S&D provides raw materials and ingredients to the pharmaceutical, food, personal care and performance chemicals industries.

Joris Coppye, group chief executive officer of Azelis comments: ‘This acquisition is one of the biggest in the entire Azelis history and is of significant strategic importance.

‘S&D is an important step change towards globalisation through the access to new markets such as Canada, Australia, Middle East and Africa.’

Excluded from the acquisition are the S&D companies involved in the pharmaceutical finished dosage, chemical synthesis and laboratory supply markets, as well as part of its cosmetic and toiletries business.

Peter Straus, co-founder and owner of S&D, has confirmed that the retained businesses will continue to operate and expand under their current management.

Belgium-based Azelis employs 1,100 people at 37 facilities in 27 countries across Europe, India and China.

Nick Britton

Nick Britton

Nick was the Managing Editor for growthbusiness.co.uk when it was owned by Vitesse Media, before moving on to become Head of Investment Group and Editor at What Investment and thence to Head of Intermediary...

Related Topics

Pharmaceutical industry